Schuler Family Foundation insider trades: Biolase (BIOL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Schuler Family Foundation reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2020 | BIOL | ↓ Sell | 9,159,221 | $0.45 | $4.1M | Direct | May 26, 2023 (889d) |
| Feb 11, 2020 | BIOL | ↑ Buy | 1,307,931 | $0.61 | $798K | Direct | May 26, 2023 (1200d) |
| Jun 19, 2015 | MBLX | ↑ Buy | 1,664,840 | $3.32 | $5.5M | Direct | Jun 23, 2015 (4d) |
| Mar 9, 2015 | HNSN | ↑ Buy | 23,077 | $650.00 | $15.0M | Direct | Mar 11, 2015 (2d) |
| Dec 30, 2010 | TTHI | ↑ Buy | 30,000 | $2.03 | $61K | Direct | Feb 15, 2011 (47d) |
| Dec 10, 2010 | TTHI | ↑ Buy | 8,700 | $2.06 | $18K | Direct | Feb 15, 2011 (67d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Schuler Family Foundation's insider trades
Schuler Family Foundation is an insider at Biolase (BIOL). Since Dec 10, 2010, it has reported 5 open-market purchases worth $21.4M and 1 sale worth $4.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include grants and awards (3 filings), conversions (2 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.